2004
DOI: 10.1073/pnas.0400567101
|View full text |Cite
|
Sign up to set email alerts
|

Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity

Abstract: Histone deacetylase (HDAC) activity, commonly correlated with transcriptional repression, was essential for transcriptional induction of IFN-stimulated genes (ISG). Inhibition of HDAC function led to global impairment of ISG expression, with little effect on basal expression. HDAC function was not required for signal transducer and activator of transcription tyrosine phosphorylation, nuclear translocation, or assembly on chromatin, but it was needed for full activity of the signal transducer and activator of t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

12
195
1
1

Year Published

2006
2006
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 196 publications
(209 citation statements)
references
References 50 publications
12
195
1
1
Order By: Relevance
“…We reasoned that combining a viral therapeutic with a compound that reversibly compromises host antiviral genetic programs could provide a means to enhance OV growth in tumor cells. Histone deacetylase inhibitors (HDIs) are small molecules currently in clinical development that have demonstrated potent anti-tumor activity but are also known to prevent the transcriptional activation of antiviral genes after IFN stimulation or virus infection (12)(13)(14)(15)(16)(17)(18)(19). Here, we demonstrate that a variety of HDIs markedly enhance OV killing of tumor cells in vitro and in vivo but do not increase OV growth in normal tissues.…”
Section: Hdac Inhibitor ͉ Oncolytic Virus ͉ Refractory Tumors ͉ Combimentioning
confidence: 85%
“…We reasoned that combining a viral therapeutic with a compound that reversibly compromises host antiviral genetic programs could provide a means to enhance OV growth in tumor cells. Histone deacetylase inhibitors (HDIs) are small molecules currently in clinical development that have demonstrated potent anti-tumor activity but are also known to prevent the transcriptional activation of antiviral genes after IFN stimulation or virus infection (12)(13)(14)(15)(16)(17)(18)(19). Here, we demonstrate that a variety of HDIs markedly enhance OV killing of tumor cells in vitro and in vivo but do not increase OV growth in normal tissues.…”
Section: Hdac Inhibitor ͉ Oncolytic Virus ͉ Refractory Tumors ͉ Combimentioning
confidence: 85%
“…Several possible target molecules exist, with inhibitors of Tyk-2 being one example. In addition, the transcription of IFN-stimulated genes could be blocked by histone deacetylase inhibitors (116,117). In fact, such drugs can reduce glomerulonephritis in the MLR-lpr/lpr mouse (118).…”
Section: Therapeutic Consequencesmentioning
confidence: 99%
“…Most cells, including these CS fibroblasts, express low but detectable levels of IFNs that are thought to be critical for priming robust induction of IFNs in response to viral infection (46). Intriguingly, HDAC activity is required for IFN-induced, but not basal, expression of IFN target genes (47). The relatively low expression of IFN-induced genes in CSB-null cells may indicate that induction by IFNs is both HDAC-and CSB-dependent, consistent with our observation that HDAC inhibitors phenocopy loss of CSB, and that both cause dysfunctional chromatin remodeling.…”
Section: Cs Maymentioning
confidence: 99%